CT 引导下微波消融术在肺癌上的临床应用进展
摘要
在控制消融时间、调控肿瘤内温度及扩展消融范围等方面具有明显优势。本文综述了微波消融术的机制、特性、现状、联
合应用及展望，期望为临床医生对微波消融的进一步理解提供参考。
关键词
全文:
PDF参考
[1]Huang, S., Yang, J., Shen, N., Xu, Q., & Zhao, Q. (2023).
Artificial intelligence in lung cancer diagnosis and prognosis:
Current application and future perspective. Seminars in Cancer
Biology, 89, 30-37.
[2]Hoy, H., Lynch, T., & Beck, M. (2019). Surgical Treatment
of Lung Cancer. Crit Care Nurs Clin North Am, 31(3), 303-313.
[3] 王洁 & 赫捷 .(2024). 原发性肺癌化疗规范化应用
中国指南（2024 版）. 中国肿瘤临床与康复 (09),525-548.
doi:10.13455/j.cnki.cjcor.113494-2024-2024-0222.
[4] 中国抗癌协会肿瘤多学科诊疗（MDT）专业委员会 ,
中国临床肿瘤学会（CSCO）小细胞肺癌专家委员会 , 中国
抗癌协会肿瘤放射治疗专业委员会 , 中国抗癌协会肺癌专业
委员会 & 中华医学会呼吸病学分会肺癌学组 . (2024). 不可
切除肺癌放疗联合免疫治疗专家共识（2024 年版）. 中华肿
瘤防治杂志 (20), 1223-1239.
[5]Zhao, Q., Wang, J., Fu, Y. L., & Hu, B. (2023).
Radiofrequency ablation for stage
cancer: Opportunities, challenges, and the road ahead. Thorac
Cancer, 14(32), 3181-3190.
[6]Ye, X., Yang, X., Hu, L., Wang, J., Ni, Y., Meng, M., . . .
Zou, Z. (2022). A study of microwave ablation for small cell lung
cancer. Journal of Cancer Research and Therapeutics, 18(2).
[7]Lin, M., Eiken, P., & Blackmon, S. (2020). Image guided
thermal ablation in lung cancer treatment. J Thorac Dis, 12(11),
7039-7047. doi:10.21037/jtd-2019-cptn-08
[8]Chockalingam, A., Konstantinidis, M., Koo, B., Moon, J.
T., Tran, A., Nourouzpour, S., . . . Nezami, N. (2022). Surgical
resection, radiotherapy and percutaneous thermal ablation for
treatment of stage 1 non-small cell lung cancer: protocol for a
systematic review and network meta-analysis. BMJ Open, 12(6).
[9]Páez-Carpio, A., Gómez, F. M., Isus Olivé, G.,
Paredes, P., Baetens, T., Carrero, E., . . . Vollmer, I. (2021).
Image-guided percutaneous ablation for the treatment of lung
malignancies: current state of the art. Insights into Imaging, 12(1).
doi:10.1186/s13244-021-00997-5
[10]Aufranc, V., Farouil, G., Abdel-Rehim, M., Smadja, P.,
Tardieu, M., Aptel, S., & Guibal, A. (2019). Percutaneous thermal
ablation of primary and secondary lung tumors: Comparison
between microwave and radiofrequency ablation. Diagn Interv
Imaging, 100(12), 781-791. doi:10.1016/j.diii.2019.07.008
[11]Reisenauer, J. S., Eiken, P. W., Callstrom, M. R.,
Johnson, G. B., Pierson, K., Lechtenberg, B., & Blackmon, S. H.
(2022). A prospective trial of CT-guided percutaneous microwave
ablation for lung tumors. Journal of Thoracic Disease, 14(4), 939-
951. doi:10.21037/jtd-21-1636
[12]Xu, F., Wei, Z., & Ye, X. (2024). Immunomodulatory
effects of microwave ablation on malignant tumors. Am J Cancer
Res, 14(6), 2714-2730. doi:10.62347/QJID8425
[13]Feng, K., & Lu, Y. (2022). Clinical analysis of systemic
chemotherapy combined with microwave ablation in the treatment
of lung cancer. Asian Journal of Surgery, 45(5), 1107-1112.
doi:10.1016/j.asjsur.2021.08.013
[14]Song, D., Yu, F., Chen, S., Chen, Y., He, Q., Zhang,
Z., . . . Wang, S. (2020). Raman spectroscopy combined with
multivariate analysis to study the biochemical mechanism of lung
cancer microwave ablation. Biomedical Optics Express, 11(2).
doi:10.1364/boe.383869
[15]. doi:10.23750/abm.
v91i10-S.10342
[16] Peng JZ, Wang CE, Bie ZX, Li YM, Li XG. Microwave
Ablation for Inoperable Stage I Non-Small Cell Lung Cancer in
Patients Aged ≥ 70 Years: A Prospective, Single-Center Study.
J Vasc Interv Radiol. 2023 Oct;34(10):1771-1776. doi: 10.1016/
j.jvir.2023.06.014. Epub 2023 Jun 16. PMID: 37331589.
[17]Li, L., Wu, K., Lai, H., & Zhang, B. (2017).
Clinical Application of CT-Guided Percutaneous Microwave
Ablation for the Treatment of Lung Metastasis from
Colorectal Cancer. Gastroenterol Res Pract, 2017, 9621585.
doi:10.1155/2017/9621585
[18]Han, Y., Yan, X., Zhi, W., Liu, Y., Xu, F., & Yan, D.
(2022). Long-term outcome following microwave ablation of lung
metastases from colorectal cancer. Front Oncol, 12, 943715.
doi:10.3389/fonc.2022.943715
[19]de Baere, T., Auperin, A., Deschamps, F., Chevallier, P.,
Gaubert, Y., Boige, V., . . . Palussiere, J. (2015). Radiofrequency
ablation is a valid treatment option for lung metastases: experience
in 566 patients with 1037 metastases. Ann Oncol, 26(5), 987-991.
doi:10.1093/annonc/mdv037
[20] Tan, C., Fisher, O. M., Huang, L., Alzahrani, N., Liauw,
W., Glenn, D., & Morris, D. L. (2022). Comparison of Microwave
and Radiofrequency Ablation in the Treatment of Pulmonary
Metastasis of Colorectal Cancer. Anticancer research, 42(9),
4563–4571. https://doi.org/10.21873/anticanres.15959
[21]Xu, S., Bie, Z. X., Li, Y. M., Qi, J., Peng, J. Z., & Li,
X. G. (2024). Maintenance treatment of immunotherapy after
microwave ablation plus drug-eluting bead bronchial arterial
chemoembolization for advanced non-small cell lung cancer: a
retrospective single-center cohort study. Quant Imaging Med Surg,
14(5), 3473-3488. doi:10.21037/qims-23-1876
[22] Shan, Y., Yin, X., Lin, F., Wang, C., Kong, Y., & Yao,
W. (2021). Chemotherapy combined with intermittent microwave
ablation in the treatment of oligometastatic non-small cell lung
cancer. Journal of B.U.ON. : official journal of the Balkan Union of
Oncology, 26(2), 320–327.
[23]Zhang, Y.-Q., Wu, Y.-L., Feng, Y., & Zhou, Y.-X.
(2022). A Clinical Study on Microwave Ablation in Combination
with Chemotherapy in Treating Peripheral IIIB–IV Non-Small
Cell Lung Cancer. Cancer Biotherapy and Radiopharmaceuticals,
37(2), 141-146. doi:10.1089/cbr.2020.3859
[24]Wei, Z., Yang, X., Ye, X., Feng, Q., Xu, Y., Zhang,
L., . . . Tian, H. (2020). Microwave ablation plus chemotherapy
versus chemotherapy in advanced non-small cell lung cancer:
a multicenter, randomized, controlled, phase III clinical trial.
European Radiology, 30(5), 2692-2702. doi:10.1007/s00330-
019-06613-x
[25]Song, P., Sun, W., Pang, M., He, W., Zhang, W., &
Sheng, L. (2021). Efficacy comparison between microwave ablation
combined with radiation therapy and radiation therapy alone for
locally advanced nonsmall-cell lung cancer. J Cancer Res Ther,
17(3), 715-719. doi:10.4103/jcrt.JCRT_633_20
[26]Weickhardt, A. J., Scheier, B., Burke, J. M., Gan, G.,
Lu, X., Bunn, P. A., Jr., . . . Camidge, D. R. (2012). Local ablative
therapy of oligoprogressive disease prolongs disease control by
tyrosine kinase inhibitors in oncogene-addicted non-small-cell
lung cancer. J Thorac Oncol, 7(12), 1807-1814. doi:10.1097/
JTO.0b013e3182745948
[27] 李 剑 飞 , 苏 文 玲 , 梁 柱 & 林 阳 兴 .(2021). 微 波 消
融联合靶向药物治疗 EGFR 阳性晚期非小细胞肺腺癌的
临 床 研 究 . 中 外 医 学 研 究 (22),10-12.doi:10.14033/j.cnki.
cfmr.2021.22.004.
[28]Ni, Y., Ye, X., Yang, X., Huang, G., Li, W., Wang, J.,
. . . Meng, M. (2020). Microwave ablation as local consolidative
therapy for patients with extracranial oligometastatic EGFR-
mutant non-small cell lung cancer without progression after first-
line EGFR-TKIs treatment. J Cancer Res Clin Oncol, 146(1),
197-203. doi:10.1007/s00432-019-03043-6
(8 摘要 Views, 108 PDF Downloads)
Refbacks
- 当前没有refback。